{"id":"W2604788765","doi":"10.1200/jco.2009.27.15_suppl.6026","title":"A phase II randomized study of oral seliciclib in patients with previously treated nasopharyngeal carcinoma","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Clinical endpoint; Dosing; Phases of clinical research; Nasopharyngeal carcinoma; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Oncology; Randomized controlled trial; Surgery; Adverse effect; Clinical trial; Radiation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002665428,0.001885315,0.003558138,0.000430894,0.0006671072,0.001203262,0.0009158641,0.001363775,0.007710707],"category_scores_gemma":[0.001646203,0.001033432,0.001243687,0.0005879618,0.00125971,0.001007296,0.0005109926,0.002885375,0.001628154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001024237,"about_ca_system_score_gemma":0.003149769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001117508,"about_ca_topic_score_gemma":0.003104576,"domain_scores_codex":[0.9992111,0.0003959993,0.00004923044,0.0001475012,0.00007316632,0.0001230181],"domain_scores_gemma":[0.9988269,0.0002137734,0.0002045359,0.0001150382,0.0001008136,0.000538803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9104849,0.05014824,0.004644644,0.0005073794,0.0009695872,0.0002103963,0.0001413569,0.0008480943,0.009250715,0.0001340655,0.002207523,0.02045303],"study_design_scores_gemma":[0.8557957,0.1379142,0.003729046,0.00001514019,0.0002360396,0.00009181092,0.00003168283,0.000488258,0.0004692361,0.00008074594,0.001131457,0.00001656496],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828834,0.001797162,0.0006788041,0.0004971615,0.0003066252,0.01077419,0.001137535,0.00009411287,0.00183101],"genre_scores_gemma":[0.973766,0.002210321,0.002071714,0.001720741,0.0003922013,0.01280563,0.002618245,0.00003683591,0.004378212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007710707,"threshold_uncertainty_score":0.02579486,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05884612129321212,"score_gpt":0.4440168656654185,"score_spread":0.3851707443722064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}